申请人:Council of Scientific & Industrial Research
公开号:US20180000776A1
公开(公告)日:2018-01-04
The present invention relates to a formulation of
Spinacea oleracea
useful for the prevention or treatment of osteo-health related disorders. The present invention relates to the field of pharmaceutical formulation that provides extract, fractions, pure compound isolated from natural sources and formulation thereof useful for the prevention and treatment of various medical indications. Further, this invention relates to conditions associated with estrogen dependent or independent diseases (primary/secondary osteoporosis) or syndromes or disorders preferably relating to cartilage such as osteoarthritis caused in humans and animals. Furthermore, this invention relates to achievement of peak bone mass during skeletal growth and health in humans and animals. Particularly, the present invention relates to the processes for the preparation of biologically active extracts, from
Spinacea oleracea
from the family Amaranthaceae their pharmaceutically acceptable excepients and compositions of the principal aspect of the present invention.
本发明涉及一种用于预防或治疗骨健康相关疾病的菠菜(Spinacea oleracea)配方。本发明涉及提供提取物、分馏物、从天然来源中分离的纯化合物以及有益于预防和治疗各种医学指示的制药配方领域。此外,本发明涉及与雌激素依赖性或非依赖性疾病(原发性/继发性骨质疏松症)或综合症或疾病相关的病症,最好是与软骨相关的疾病,如人类和动物中引起的骨关节炎。此外,本发明涉及在人类和动物的骨骼生长和健康过程中达到峰值骨量的实现。特别是,本发明涉及从苋科植物家族的菠菜(Spinacea oleracea)中制备具有生物活性的提取物的过程,其具有药学上可接受的辅料和本发明主要方面的组合。